Author

Logan Thrasher Collins

Washington University in St. LouisORCID 0000-0003-1239-4310Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

Ayrea E. HurleyiD· 2 shared Buhle MoyoiD· 2 shared David T. CurieliD· 2 shared Gang BaoiD· 2 shared Michele Alves‐BezerraiD· 2 shared Wandy L. BeattyiD· 2 shared William R. LagoriD· 2 shared Leonard H. RomeiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Ayrea E. HurleyORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringACS Synthetic BiologyPeer-reviewedAug 13, 2026

Encapsulation of AAVs into protein vault nanoparticles as a novel solution to gene therapy's neutralizing antibody problem

Logan Thrasher Collins, Wandy L. Beatty, Buhle Moyo…·David T. Curiel

This study encapsulates AAVs into protein vault nanoparticles to bypass neutralizing antibodies, enabling effective gene therapy despite preexisting immunity.

3 citations

humanexperimental assay

𝕏 PostBluesky

Synthetic BiologybioRxivPreprintAug 21, 2024

Covalently linked adenovirus-AAV complexes as a novel platform technology for gene therapy

Logan Thrasher Collins, Wandy L. Beatty, Paul Boucher…·Zhi Hong Lu

This paper introduces a novel gene therapy platform using covalently linked adenovirus-AAV complexes to improve co-infection efficiency and reduce AAV dose requirements.

1 citation

experimental assay

𝕏 PostBluesky